Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors.

Kerr, Jonathan R

Kerr, Jonathan R.

Affiliation

Kerr JR; Department of Microbiology, West Suffolk Hospitals NHS Trust, Bury Saint Edmunds, Suffolk, UK jonathan@ssl-mail.com.

J Clin Pathol ; 72(10): 651-658, 2019 Oct.

Article in En | MEDLINE | ID: mdl-31315893

Subject(s)

Antiviral Agents/therapeutic use; Dietary Supplements; Epstein-Barr Virus Infections/virology; Genome, Viral/genetics; Herpesvirus 4, Human/physiology; Vitamins; B-Lymphocytes/virology; Epstein-Barr Virus Infections/drug therapy; Epstein-Barr Virus Infections/psychology; Herpesvirus 4, Human/drug effects; Herpesvirus 4, Human/pathogenicity; Host-Pathogen Interactions; Humans; Stress, Psychological; Virus Activation/drug effects; Virus Latency; Virus Replication/drug effects

Key words

Epstein-Barr virus; dietary supplement; lytic phase; pathogenesis; psychological stress; reactivation; therapeutic inhibitors; vitamins

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Vitamins / Genome, Viral / Herpesvirus 4, Human / Dietary Supplements / Epstein-Barr Virus Infections Language: En Journal: J Clin Pathol Year: 2019 Type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google